Floatz logo

Bifidobacterium Tetravaccae

Abdominal Obesity-Metabolic Syndrome

Nanjing First Hospital, Nanjing Medical UniversityUNKNOWNPhase 4 / ApprovedActive
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
73/ 100

Competitive context

41 Active assets in the Abdominal Obesity-Metabolic Syndrome cohort.

Asset / SponsorPhaseRating
Topiramate
All India Institute of Medical Sciences, Bhubaneswar
Phase 4BBB
Atorvastatin
Seoul National University Hospital
Phase 4BBB
Pioglitazone
Philip Kern
Phase 4BBB
Rosuvastatin
Hamdard University
Phase 4BBB
Simvastatin
Jaime Daniel Mondragon
Phase 4BBB

View all 50 →

Same molecule, other indications

Bifidobacterium Tetravaccae is also rated in:

Helicobacter pylori infectious diseaseActive
BB
Indicative · Phase 4
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →